BioRad Laboratories, headquartered in Hercules, California, develops specialty chemicals and offers products for biochemical, pharmaceutical, and life science research, employing 8,030 people. It operates in Life Science and Clinical Diagnostics segments, serving various laboratory markets.
Michael Crowley sold 3,000 shares of BIO on 14 March at $247.06 per share, worth a total of $741K. They now own 8,171 BIO shares, or a 27% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.